Abstract: Described herein are isolated cell culture components such as, e.g., biologics and/or lipids, and methods for isolating cell culture components from a liquid cell culture medium. Methods of the present invention may include contacting a dehydration composition and a liquid cell culture medium comprising a target component to form a mixture; forming an at least partially dehydrated component in the mixture; and separating the at least partially dehydrated component from the mixture, thereby providing an isolated component. In some embodiments, the isolated component comprises the at least partially dehydrated component. In some embodiments, the isolated component is present in a composition (e.g., liquid phase) separated from the at least partially dehydrated component.

Abstract: Disclosed herein are CdTe-based solar cells that are successfully removed from their glass superstrate through a combination of lamination to a backsheet followed by thermal shock.

Abstract: Described herein are isolated cell culture components such as, e.g., biologics and/or lipids, and methods for isolating cell culture components from a liquid cell culture medium. Methods of the present invention may include contacting a dehydration composition and a liquid cell culture medium comprising a target component to form a mixture; forming an at least partially dehydrated component in the mixture; and separating the at least partially dehydrated component from the mixture, thereby providing an isolated component. In some embodiments, the isolated component comprises the at least partially dehydrated component. In some embodiments, the isolated component is present in a composition (e.g., liquid phase) separated from the at least partially dehydrated component.

Abstract: A recirculation system for a power system is disclosed. The recirculation system may determine, according to a sequence for individually activating a plurality of turbochargers of an engine, that a designated turbocharger of the plurality of turbochargers is to be activated. The recirculation system may cause a recirculation valve of a recirculation line to open to increase an airflow between an intake manifold and a compressor of the designated turbocharger.

Abstract: Described herein are isolated cell culture components such as, e.g., biologics and/or lipids, and methods for isolating cell culture components from a liquid cell culture medium. Methods of the present invention may include contacting a dehydration composition and a liquid cell culture medium comprising a target component to form a mixture; forming an at least partially dehydrated component in the mixture; and separating the at least partially dehydrated component from the mixture, thereby providing an isolated component. In some embodiments, the isolated component comprises the at least partially dehydrated component. In some embodiments, the isolated component is present in a composition (e.g., liquid phase) separated from the at least partially dehydrated component.

Abstract: A recirculation system for a power system is disclosed. The recirculation system may determine, according to a sequence for individually activating a plurality of turbochargers of an engine, that a designated turbocharger of the plurality of turbochargers is to be activated. The recirculation system may cause a recirculation valve of a recirculation line to open to increase an airflow between an intake manifold and a compressor of the designated turbocharger.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: An apparatus for playing a game includes a plurality of channels, each of the plurality of channels configured to hold and display a column of spherical game-pieces, each of the plurality of channels having an upper end and a lower end, each upper end configured to individually receive at least one of the spherical game-pieces, each lower end configured to support a respective column of spherical game-pieces by preventing passage of a bottom game-piece from a respective channel; a funnel affixed to the plurality of channels and configured to receive a thrown spherical game-piece and to direct the thrown spherical game-piece into the upper end of one of the plurality of channels; and a base stand operably connected to the plurality of channels and configured to rest upon a horizontal surface and to retain the plurality of channels at an acute angle relative to the horizontal surface.

Abstract: Disclosed herein are CdTe-based solar cells that are successfully removed from their glass superstrate through a combination of lamination to a backsheet followed by thermal shock.

Abstract: An apparatus for playing a game includes a plurality of channels, each of the plurality of channels configured to hold and display a column of spherical game-pieces, each of the plurality of channels having an upper end and a lower end, each upper end configured to individually receive at least one of the spherical game-pieces, each lower end configured to support a respective column of spherical game-pieces by preventing passage of a bottom game-piece from a respective channel; a funnel affixed to the plurality of channels and configured to receive a thrown spherical game-piece and to direct the thrown spherical game-piece into the upper end of one of the plurality of channels; and a base stand operably connected to the plurality of channels and configured to rest upon a horizontal surface and to retain the plurality of channels at an acute angle relative to the horizontal surface.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: An apparatus for playing a game includes a first plurality of spherical game-pieces of a first color and a second plurality of spherical game-pieces of a second color, each sized and dimensioned to be thrown by hand. A base stand that supports a plurality of vertically oriented channels each configured to hold and display a column of the spherical game-pieces. A funnel is affixed to the base stand that is configured to receive a thrown game-piece, and to direct the thrown game-piece into the upper end of one of plurality of vertically oriented channels. A storage container may be located under the plurality of vertical channels configured to receive and store the game-pieces. The apparatus for playing a game is useful for playing a game with at least one participant.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.